Epidermal Growth Factor Receptor (EGFR) Mutation Testing and First Line Treatment with Gefitinib is a Dominant Strategy in the Treatment of Asian and European Patients with Advanced Non-small Cell Lung Cancer (NSCLC)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者LOPES Dl Gilberto, SEGEL Joel, TAN Daniel, DO Young, NOVELLO Silvia, MOK Shu Kam Tony, SCAGLIOTTI Giorgio, FINKELSTEIN Eric
會議名稱Proceedings of the 14th World Conference on Lung Cancer
會議國家/地區美國
會議論文集題名Proceedings of the 14th World Conference on Lung Cancer
詳細描述organized by IASLC,
出版年份2011
月份6
出版地United States of America
頁次1179
語言英式英語
關鍵詞EGFR mutation; Asian and European patients; NSCLC

上次更新時間 2018-18-01 於 18:23